| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 208.84B | 207.17B | 187.46B | 191.08B | 191.25B | 174.17B |
| Gross Profit | 52.20B | 51.68B | 46.54B | 42.35B | 40.21B | 41.87B |
| EBITDA | 21.49B | 21.32B | 18.59B | 14.94B | 14.49B | 16.36B |
| Net Income | 13.95B | 14.05B | 12.20B | 9.60B | 9.28B | 10.01B |
Balance Sheet | ||||||
| Total Assets | 128.60B | 134.18B | 120.73B | 102.19B | 95.22B | 87.36B |
| Cash, Cash Equivalents and Short-Term Investments | 51.45B | 57.73B | 48.52B | 41.14B | 24.57B | 31.81B |
| Total Debt | 14.39B | 13.44B | 14.97B | 10.09B | 12.71B | 9.29B |
| Total Liabilities | 41.51B | 44.66B | 41.38B | 33.90B | 35.94B | 35.03B |
| Stockholders Equity | 86.89B | 89.32B | 79.18B | 67.22B | 58.37B | 51.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.08B | 5.04B | 21.33B | -7.99B | 11.29B |
| Operating Cash Flow | 0.00 | 17.59B | 8.20B | 24.02B | -6.76B | 13.17B |
| Investing Cash Flow | 0.00 | -24.83B | -6.20B | -2.74B | -1.19B | -1.52B |
| Financing Cash Flow | 0.00 | -8.12B | -132.00M | -5.81B | 224.00M | -4.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥225.89B | 14.42 | ― | 2.70% | 10.23% | 8.78% | |
79 Outperform | ¥157.72B | 7.21 | 12.77% | 2.84% | 4.48% | 22.39% | |
76 Outperform | ¥148.12B | 22.80 | ― | 1.92% | 7.46% | -8.01% | |
72 Outperform | ¥107.52B | 14.90 | 17.33% | 4.06% | -8.93% | 48.98% | |
69 Neutral | ¥91.05B | 18.25 | ― | 4.76% | 1.81% | 9.07% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥167.03B | -26.53 | -6.22% | 1.61% | -4.91% | -136.94% |
BCPE Meta Cayman, L.P., which is conducting a tender offer for the shares of MCJ Co., Ltd., has filed an amendment to its tender offer registration statement following a shortened waiting period under Japan’s Foreign Exchange and Foreign Trade Act. As a result, it has issued an amended public notice of commencement of the tender offer, clarifying conditions under which the offer may be withdrawn in relation to regulatory approvals, while confirming that key purchase terms for shareholders remain unchanged.
The updated notice addresses how the tender offeror may treat situations where competition or foreign investment approvals from authorities such as the European Commission and the Australian Competition and Consumer Commission cannot be obtained by the end of the offer period. These procedural clarifications refine the legal and regulatory framework of the transaction without altering economic conditions for tendering shareholders, indicating that the deal is progressing within expected regulatory channels while preserving offer terms for investors.
The most recent analyst rating on (JP:6670) stock is a Buy with a Yen2636.00 price target. To see the full list of analyst forecasts on MCJ Co., Ltd. stock, see the JP:6670 Stock Forecast page.
BCPE Meta Cayman, L.P., which launched a tender offer on February 6, 2026 for the common shares of MCJ Co., Ltd., has amended its public notice of commencement of the offer after receiving a Notice of Decision Not to Issue a Cease and Desist Order and a Notice of Shortening of the Prohibition Period from the Japan Fair Trade Commission. The tender offer registration statement and related public notice were updated to reflect these regulatory developments, but the company emphasized that the amendments do not alter the core purchase terms of the offer, limiting the impact mainly to procedural and disclosure aspects for investors and other stakeholders.
The amendments relate to conditions under which the tender offer could be withdrawn, particularly in connection with competition approvals in Japan, the European Union and Australia, and clarify how these regulatory processes affect the offer’s continuation. By confirming that the substantive terms of the tender offer remain unchanged, BCPE Meta Cayman, L.P. aims to provide greater certainty to the market and MCJ shareholders while demonstrating progress in securing necessary antitrust clearances, an important step in advancing the proposed acquisition.
The most recent analyst rating on (JP:6670) stock is a Buy with a Yen2615.00 price target. To see the full list of analyst forecasts on MCJ Co., Ltd. stock, see the JP:6670 Stock Forecast page.
MCJ Co., Ltd. has announced that its board of directors has resolved to support a management buyout (MBO) led by BCPE Meta Cayman, L.P., a Bain Capital–related investment vehicle formed in January 2026 to acquire and control MCJ’s business, and to recommend that shareholders tender their shares into the proposed tender offer at 2,200 yen per share. The deal, backed by Chairman and CEO and largest shareholder Yuji Takashima—who plans to remain involved in management and reinvest through an asset management vehicle—aims to take MCJ private via the tender offer and subsequent squeeze-out, marking a significant ownership and governance shift that will delist the company and consolidate control under the MBO sponsor and incumbent management.
The most recent analyst rating on (JP:6670) stock is a Buy with a Yen1819.00 price target. To see the full list of analyst forecasts on MCJ Co., Ltd. stock, see the JP:6670 Stock Forecast page.